March 2, 2018 / 7:37 AM / in 6 months

BRIEF-Oasmia Pharmaceutical Q3 sales rise, smaller operating loss

March 2 (Reuters) - Oasmia Pharmaceutical Ab:

* Q3 ‍CONSOLIDATED NET SALES AMOUNTED TO TSEK 656 COMPARED TO TSEK 36 IN Q3 PREVIOUS YEAR​

* Q3 ‍OPERATING LOSS WAS TSEK 25,158 COMPARED TO TSEK 34,861 IN Q3 PREVIOUS YEAR​ Source text for Eikon: Further company coverage: (Stockholm Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below